Kuopio, Finland

Mikko Kananen

This inventor holds 3 USPTO granted patents. Top assignee: Orion Corporation. Active years: 2002-2005.


% Patents Active = 33.3

Average Co-Inventor Count = 7.0

ph-index = 2

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2002-2005

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Mikko Kananen: Innovator in Pharmaceutical Compositions

Introduction

Mikko Kananen is a notable inventor based in Kuopio, Finland. He has made significant contributions to the field of pharmaceuticals, particularly in the development of soluble compositions of triphenylethylene antiestrogens. His innovative work has led to the filing of multiple patents, showcasing his expertise and dedication to advancing medical science.

Latest Patents

Mikko Kananen holds 3 patents related to his research. His latest patents include formulations for aqueous compositions of nonsteroidal triphenylethylene antiestrogens. These compositions utilize a solubility enhancing agent, which is a pharmaceutically acceptable mono- or dicarboxylic acid with 1-5 carbon atoms. The carbon chain may also contain hydroxyl, oxo, or halogen substituents, or a corresponding anion, along with methanesulfonic acid or its anion. Additionally, these formulations may include organic water-miscible co-solvents such as polyethylene glycol (PEG), propylene glycol, ethanol, or isopropanol.

Career Highlights

Mikko Kananen is currently associated with Orion Corporation, where he continues to innovate in the pharmaceutical sector. His work focuses on enhancing the solubility and efficacy of antiestrogen compounds, which are crucial in various therapeutic applications.

Collaborations

Mikko has collaborated with esteemed colleagues, including Kaija Af Ursin and Heikki Niskanen. Their combined expertise contributes to the advancement of research and development in their field.

Conclusion

Mikko Kananen's contributions to pharmaceutical innovations highlight his role as a key inventor in the industry. His patents reflect a commitment to improving drug formulations and enhancing patient care.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…